Market Summary: The global market for tuberculosis diagnostics is projected to reach USD 2.91 billion by 2030, with a projected revenue compound annual growth rate (CAGR) of 6.0% over the forecast period. The primary driver for this revenue growth is the increasing prevalence of tuberculosis worldwide, particularly in developing economies. Additionally, substantial investments in the development of more effective diagnostic technologies to improve patient outcomes and accuracy have contributed to the market’s growth. In 2020, the World Health Organization (WHO) reported that 1.1 million children worldwide were infected with tuberculosis, further emphasizing the global tuberculosis burden. The majority of new cases were reported in 30 high tuberculosis-burden countries, with countries like Indonesia, China, India, and South Africa accounting for a significant portion of the cases. These high incidence rates have significantly contributed to the market’s revenue growth during the forecast period.
Recent advancements in tuberculosis diagnostics have played a significant role in driving market revenue growth. The increasing demand for accurate diagnostic assays at all levels of the healthcare system has also significantly contributed to market revenue growth. Accurate diagnosis is especially crucial in the early stages of the disease to reduce morbidity, mortality, and transmission risk.
Get a sample copy of the Tuberculosis Diagnostics Market report: https://www.reportsanddata.com/download-free-sample/3742
Market Dynamics: Driving Factors:
- Rapid Product Innovations and Community Support Schemes: Community support programs are crucial for ensuring the availability and use of effective tuberculosis treatment methods. These programs can provide nutritional support, diagnostics, and vocational training. The introduction of such schemes in countries like India is a significant driver for market growth.
- Product Innovations: Substantial investments in research and development have led to improved diagnostic performance and clarity in the diagnosis of tuberculosis, particularly in cases of drug resistance. Automation technologies have been instrumental in achieving these advancements.
- Advancements in Disease Detection: Recent advancements in disease detection, such as molecular tests for tuberculosis, have led to improved diagnostic accuracy and faster results.
Challenges:
- Limitations of Existing Diagnostics: Certain technological complications associated with existing tuberculosis diagnostics, such as low sensitivity, especially in certain patient populations, can hinder market growth.
- Technical Complexity: Developing diagnostic technologies for tuberculosis can be technically challenging, and the existing methods may not be suitable for all cases.
Disease Stage Insights: The global tuberculosis diagnostics market is segmented into latent tuberculosis and active tuberculosis. The active tuberculosis segment accounted for the largest revenue share in 2021 due to the higher number of deaths associated with tuberculosis. Technological advancements, investments in research and development, and the introduction of rapid molecular tests have all contributed to market growth in this segment.
Test Type Insights: The market is further segmented based on test type, including radiographic methods, cytokine detection assays, nucleic acid testing, detection of latent infection, diagnostics laboratory methods, detection of drug resistance, and other methods. The nucleic acid testing segment accounted for the largest revenue share in 2021, driven by the availability of recommendations for using nucleic acid amplification tests for tuberculosis diagnosis. The rapid adoption of nucleic acid testing in high-burden countries has significantly contributed to market growth.
End-User Insights: End-users are categorized into clinics, research institutes and academics, and reference laboratories. Reference laboratories accounted for a significant revenue share in 2021, primarily due to the rise in drug-resistant tuberculosis infections and the adoption of advanced microscopy techniques. Automation technologies are also playing a crucial role in laboratories, driving the adoption of tuberculosis diagnostic tools.
Regional Insights:
- Asia Pacific: This region accounted for the largest revenue share in 2021, with increasing tuberculosis cases and a high mortality rate driving market growth. Initiatives by organizations like the United States Agency for International Development (USAID) have contributed to tuberculosis control and prevention in the Asia-Pacific region.
- Europe: Europe accounted for the second-largest revenue share in 2021, with significant investments in healthcare facilities and awareness-raising strategies related to tuberculosis diagnosis and treatment.
- North America: North America was the third-largest revenue contributor in 2021, with the presence of key market players like Thermo Fisher Scientific and Abbott. The prevalence of tuberculosis and advancements in pathogen-specific metabolic pathways have driven market growth in this region.
Competitive Landscape: The global tuberculosis diagnostics market is characterized by a fragmented competitive landscape with key players operating on both global and regional levels. Major players in the market include Abbott, Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd, Qiagen, Cepheid, Hologic, Inc., Hain Lifescience GmbH, PerkinElmer Inc., BioMerieux SA, and BD. These players are actively involved in product development and strategic alliances to expand their product portfolios and strengthen their market presence.
Notable Initiatives:
- PerkinElmer Inc.: The company announced the commercialization of its T-Cell Select reagent kit, approved by the FDA for in vitro diagnostics. This kit automates workflows, reduces hands-on time, and enhances blood sample stability.
- Thermo Fisher Scientific: The company collaborated with NanoPin Technologies, Inc. to advance blood-based infectious disease detection technology, resulting in highly sensitive clinical assays for infectious diseases.
Segments Covered in the Report: This report segments the tuberculosis diagnostics market based on disease stage, test type, end-user, and region.
Market Report Scope:
- Market Size in 2021: USD 1.71 Billion
- CAGR (2021 – 2030): 6.0%
- Revenue Forecast in 2030: USD 2.91 Billion
Explore Trending Reports:
Diabetes Devices Market-https://www.globenewswire.com/news-release/2019/06/10/1866428/0/en/Diabetes-Devices-Market-To-Reach-USD-38-53-Billion-By-2026-Reports-And-Data.html
Aesthetic Lasers Market-https://www.globenewswire.com/news-release/2019/05/02/1815515/0/en/Aesthetic-Lasers-Market-To-Reach-USD-1-93-Billion-By-2026-Reports-And-Data.html
Capsule Endoscopy Market-https://www.globenewswire.com/news-release/2019/08/06/1897810/0/en/Capsule-Endoscopy-Market-To-Reach-USD-1-30-Billion-By-2026-Reports-And-Data.html
Brain Pacemaker Market-https://www.globenewswire.com/news-release/2019/10/07/1925979/0/en/Brain-Pacemaker-Market-To-Reach-USD-3-740-81-Million-by-2026-Reports-And-Data.html
Request a customization of the report: https://www.reportsanddata.com/request-customization-form/3742
Thank you for reading our report. To know more about the customization or any query about the report contents, please connect with us and our team will ensure the report is tailored to meet your requirements.
About Reports and Data   Â
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
(Head of Business Development)
Reports and Data | Web:Â www.reportsanddata.com
Direct Line:Â +1-212-710-1370
E-mail:Â sales@reportsanddata.com
Blogs | Press Release | Industry News | Our competencies
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @Â https://www.reportsanddata.com/report
Browse Latest Blogs: https://www.reportsanddata.com/blogs
Browse Latest Press Release: https://www.reportsanddata.com/press-release